Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function

by Laura Damele, Laura Damele, Elisa Montaldo, Lorenzo Moretta, Chiara Vitale, Chiara Vitale, Maria Cristina Mingari, Maria Cristina Mingari, Maria Cristina Mingari
Published 2018-10-01

Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?

by Laura Damele, Selene Ottonello, Maria Cristina Mingari, Gabriella Pietra, Chiara Vitale
Published 2020-03-01

EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34⁺ Cells

by Laura Damele, Adriana Amaro, Alberto Serio, Silvia Luchetti, Ulrich Pfeffer, Maria Cristina Mingari, Chiara Vitale
Published 2021-01-01